Statistics for MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design
Total visits
| views | |
|---|---|
| MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design | 4 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:3ac824cb-0dd3-4e5e-bbff-a3797954d0df | 24 |
| java.util.UUID:671016f4-a74f-488f-91cb-c43116e41759 | 12 |
| Oskarsson2021MN166-CCBYNCND.pdf | 10 |
| java.util.UUID:5a4ded6b-5458-4f86-93e7-598e9ed37d6e | 6 |
Top country views
| views | |
|---|---|
| United States | 3 |
| Argentina | 1 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |
| Franklin | 1 |
| San Isidro | 1 |